Read + Share
Amedeo Smart
Independent Medical Education
Gou X, Anurag M, Lei JT, Kim BJ, et al. Transcriptional reprogramming differentiates active from inactive ESR1 fusions in endocrine therapy-refractory metastatic breast cancer. Cancer Res 2021 Oct 28. pii: 0008-5472.CAN-21-1256.PMID: 34711608
Email
LinkedIn
Facebook
Twitter
Privacy Policy